Director, Product Development
Current• Head of R&D for Stanmore Implants, UK. Managed a $20M Limb Salvage portfolio and Patient Specific Solutions business units in the US, UK, Ireland, and India. • Divisional lead responsible for Patient-Specific and limb salvage strategy. Collaborated with marketing and commercial leaders on product road mapping based on VOC, and competitive assessments. Currently leading the development of a $45M acetabular revision portfolio.• Proficient in all facets of business development, encompassing target identification, conducting comprehensive due diligence, negotiating deals, and overseeing seamless integration and divestiture processes.• Spearheaded the development of the Electron Beam Melting (EBM) Additive Manufacturing process, a groundbreaking achievement that revolutionized the production of complex Patient-Specific Implants. This innovative technology not only reduced costs but also significantly shortened lead times, making it a remarkable first for the company. • Successfully drove business process improvements by introducing cutting-edge auto segmentation technology for limb salvage procedures. Through this innovative solution, we significantly reduced 3D planning and design lead times by an impressive 60%, optimizing efficiency and expediting patient care.• Streamlined communication between surgeons and development teams by launching an electronic request-handling platform, enabling swift and efficient collaboration. This innovative platform dramatically improved communication lead times by an impressive 90%, enhancing productivity and ensuring seamless coordination among all stakeholders.• Led global expansion of the Patient-Specific Solutions business. Established a Customs Manufacturing Cell in Mahwah, NJ which resulted in 231% growth in 2 years. • Demonstrated expertise in navigating design controls and regulatory processes to obtain 510K clearances and ISO 13485 certifications.